| Funding opportunity/notice . | Participating ICOs . |
|---|---|
| A new research education program from ORWH, Galvanizing Health Equity through Novel and Diverse Educational Resources (GENDER) R25 (RFA-OD-22-015) will support the development of courses, curricula, or methods focused on how health is influenced by gender, as an identity, social, cultural, or structural variable, and/or sex, as a biological variable | ORWH; NIA; NIAMS; NIDA; NIMHD; NLM; NIDCR; OBSSR; OAR; SGMRO |
| ORWH’s U3 program (Understudied, Underrepresented, and Underreported) includes administrative supplements (NOT-OD-22-208) targeting interdisciplinary, transdisciplinary, and multidisciplinary research focused on the effects of sex and/or gender influences at the intersection of several social determinants—including, but not limited to, race, ethnicity, socioeconomic status, education, health literacy, gender identity, and urban or rural residence—in human health and illness | ORWH; NEI; NHLBI; NIA; NIAAA; NIAID; NIAMS; NIBIB; NICHD; NIDCD; NIDCR; NIDDK; NIDA; NIEHS; NIGMS; NIMH; NINDS; NINR; NCCIH; NCI; SGMRO; ONR |
| NIAID’s Transgender People: Immunity, Prevention, and Treatment of HIV and STIs R21 (PAR-22-186) will support short duration, high-risk and innovative, hypothesis-generating research focused on describing the systemic and mucosal impact of the drugs, hormones and surgical interventions used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI) in transgender people | NIAID |
| NIAID’s American Women: Assessing Risk Epidemiologically (AWARE) R01 (RFA-AI-21-058) will support research that combines epidemiologic methods, digital technology, and data science approaches to better understand HIV prevention, transmission, and early care-cascade points for women living in the USA | NIAID; NIAAA; NICHD; NIDA; NIMH; OBSSR; ORWH |
| NICHD’s Multipurpose Prevention Technology: Novel Systemic Options for Young Adults R43/R44 (PAR-21-297) and NIAID’s Next Generation Multipurpose Prevention Technologies (NGM) R01 (PAR-22-222) will support development of multipurpose technologies that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women, and encourages bio-behavioural and behavioural/social studies to identify MPT end user preferences factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT use in adolescent and young women | NICHD; NIAID; NIMH |
| NIA’s Sex and Gender Differences in AD/ADRD (NOT-AG-21-050) Notice of Special Interest (NOSI) promotes multidisciplinary research to clarify sex and gender differences in the risk, development, progression, diagnosis, and clinical presentation of Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). It includes social level factors (e.g., history of maltreatment or adversity, parenthood, marital status, educational attainment, socioeconomic and employment status) and healthcare system-level (e.g., access to care) factors and processes that separately, or together, may drive observed differences by sex and gender and/or may operate differently by sex and gender | NIA |
| NIMH’s Notice of Information on High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and Mental Health of Girls and Young Women (Ages 12-24) (NOT-MH-22-245) outlines NIMH priorities in the field of women’s mental health research, including research projects that examine biological, social, cultural, and behavioural contributions of sex and gender influences on mental illnesses (e.g., anxiety, depression, psychosis, schizophrenia, bipolar disorder, trauma-related disorders, eating disorders, etc.) autism spectrum disorder and suicide in adolescent girls and young women | NIMH |
| NIDA’s Notice of Special Interest (NOSI) on Mechanistic studies on the impact of substance use in sex and gender differences in HIV-associated neurocognitive disorders (NOT-DA-22-047) communicates NIDA’s special interest in understanding the neurobiological bases for sex or gender-specific differences in HIV-associated neurocognitive disorders | NIDA |
| Funding opportunity/notice . | Participating ICOs . |
|---|---|
| A new research education program from ORWH, Galvanizing Health Equity through Novel and Diverse Educational Resources (GENDER) R25 (RFA-OD-22-015) will support the development of courses, curricula, or methods focused on how health is influenced by gender, as an identity, social, cultural, or structural variable, and/or sex, as a biological variable | ORWH; NIA; NIAMS; NIDA; NIMHD; NLM; NIDCR; OBSSR; OAR; SGMRO |
| ORWH’s U3 program (Understudied, Underrepresented, and Underreported) includes administrative supplements (NOT-OD-22-208) targeting interdisciplinary, transdisciplinary, and multidisciplinary research focused on the effects of sex and/or gender influences at the intersection of several social determinants—including, but not limited to, race, ethnicity, socioeconomic status, education, health literacy, gender identity, and urban or rural residence—in human health and illness | ORWH; NEI; NHLBI; NIA; NIAAA; NIAID; NIAMS; NIBIB; NICHD; NIDCD; NIDCR; NIDDK; NIDA; NIEHS; NIGMS; NIMH; NINDS; NINR; NCCIH; NCI; SGMRO; ONR |
| NIAID’s Transgender People: Immunity, Prevention, and Treatment of HIV and STIs R21 (PAR-22-186) will support short duration, high-risk and innovative, hypothesis-generating research focused on describing the systemic and mucosal impact of the drugs, hormones and surgical interventions used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI) in transgender people | NIAID |
| NIAID’s American Women: Assessing Risk Epidemiologically (AWARE) R01 (RFA-AI-21-058) will support research that combines epidemiologic methods, digital technology, and data science approaches to better understand HIV prevention, transmission, and early care-cascade points for women living in the USA | NIAID; NIAAA; NICHD; NIDA; NIMH; OBSSR; ORWH |
| NICHD’s Multipurpose Prevention Technology: Novel Systemic Options for Young Adults R43/R44 (PAR-21-297) and NIAID’s Next Generation Multipurpose Prevention Technologies (NGM) R01 (PAR-22-222) will support development of multipurpose technologies that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women, and encourages bio-behavioural and behavioural/social studies to identify MPT end user preferences factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT use in adolescent and young women | NICHD; NIAID; NIMH |
| NIA’s Sex and Gender Differences in AD/ADRD (NOT-AG-21-050) Notice of Special Interest (NOSI) promotes multidisciplinary research to clarify sex and gender differences in the risk, development, progression, diagnosis, and clinical presentation of Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). It includes social level factors (e.g., history of maltreatment or adversity, parenthood, marital status, educational attainment, socioeconomic and employment status) and healthcare system-level (e.g., access to care) factors and processes that separately, or together, may drive observed differences by sex and gender and/or may operate differently by sex and gender | NIA |
| NIMH’s Notice of Information on High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and Mental Health of Girls and Young Women (Ages 12-24) (NOT-MH-22-245) outlines NIMH priorities in the field of women’s mental health research, including research projects that examine biological, social, cultural, and behavioural contributions of sex and gender influences on mental illnesses (e.g., anxiety, depression, psychosis, schizophrenia, bipolar disorder, trauma-related disorders, eating disorders, etc.) autism spectrum disorder and suicide in adolescent girls and young women | NIMH |
| NIDA’s Notice of Special Interest (NOSI) on Mechanistic studies on the impact of substance use in sex and gender differences in HIV-associated neurocognitive disorders (NOT-DA-22-047) communicates NIDA’s special interest in understanding the neurobiological bases for sex or gender-specific differences in HIV-associated neurocognitive disorders | NIDA |
| Funding opportunity/notice . | Participating ICOs . |
|---|---|
| A new research education program from ORWH, Galvanizing Health Equity through Novel and Diverse Educational Resources (GENDER) R25 (RFA-OD-22-015) will support the development of courses, curricula, or methods focused on how health is influenced by gender, as an identity, social, cultural, or structural variable, and/or sex, as a biological variable | ORWH; NIA; NIAMS; NIDA; NIMHD; NLM; NIDCR; OBSSR; OAR; SGMRO |
| ORWH’s U3 program (Understudied, Underrepresented, and Underreported) includes administrative supplements (NOT-OD-22-208) targeting interdisciplinary, transdisciplinary, and multidisciplinary research focused on the effects of sex and/or gender influences at the intersection of several social determinants—including, but not limited to, race, ethnicity, socioeconomic status, education, health literacy, gender identity, and urban or rural residence—in human health and illness | ORWH; NEI; NHLBI; NIA; NIAAA; NIAID; NIAMS; NIBIB; NICHD; NIDCD; NIDCR; NIDDK; NIDA; NIEHS; NIGMS; NIMH; NINDS; NINR; NCCIH; NCI; SGMRO; ONR |
| NIAID’s Transgender People: Immunity, Prevention, and Treatment of HIV and STIs R21 (PAR-22-186) will support short duration, high-risk and innovative, hypothesis-generating research focused on describing the systemic and mucosal impact of the drugs, hormones and surgical interventions used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI) in transgender people | NIAID |
| NIAID’s American Women: Assessing Risk Epidemiologically (AWARE) R01 (RFA-AI-21-058) will support research that combines epidemiologic methods, digital technology, and data science approaches to better understand HIV prevention, transmission, and early care-cascade points for women living in the USA | NIAID; NIAAA; NICHD; NIDA; NIMH; OBSSR; ORWH |
| NICHD’s Multipurpose Prevention Technology: Novel Systemic Options for Young Adults R43/R44 (PAR-21-297) and NIAID’s Next Generation Multipurpose Prevention Technologies (NGM) R01 (PAR-22-222) will support development of multipurpose technologies that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women, and encourages bio-behavioural and behavioural/social studies to identify MPT end user preferences factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT use in adolescent and young women | NICHD; NIAID; NIMH |
| NIA’s Sex and Gender Differences in AD/ADRD (NOT-AG-21-050) Notice of Special Interest (NOSI) promotes multidisciplinary research to clarify sex and gender differences in the risk, development, progression, diagnosis, and clinical presentation of Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). It includes social level factors (e.g., history of maltreatment or adversity, parenthood, marital status, educational attainment, socioeconomic and employment status) and healthcare system-level (e.g., access to care) factors and processes that separately, or together, may drive observed differences by sex and gender and/or may operate differently by sex and gender | NIA |
| NIMH’s Notice of Information on High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and Mental Health of Girls and Young Women (Ages 12-24) (NOT-MH-22-245) outlines NIMH priorities in the field of women’s mental health research, including research projects that examine biological, social, cultural, and behavioural contributions of sex and gender influences on mental illnesses (e.g., anxiety, depression, psychosis, schizophrenia, bipolar disorder, trauma-related disorders, eating disorders, etc.) autism spectrum disorder and suicide in adolescent girls and young women | NIMH |
| NIDA’s Notice of Special Interest (NOSI) on Mechanistic studies on the impact of substance use in sex and gender differences in HIV-associated neurocognitive disorders (NOT-DA-22-047) communicates NIDA’s special interest in understanding the neurobiological bases for sex or gender-specific differences in HIV-associated neurocognitive disorders | NIDA |
| Funding opportunity/notice . | Participating ICOs . |
|---|---|
| A new research education program from ORWH, Galvanizing Health Equity through Novel and Diverse Educational Resources (GENDER) R25 (RFA-OD-22-015) will support the development of courses, curricula, or methods focused on how health is influenced by gender, as an identity, social, cultural, or structural variable, and/or sex, as a biological variable | ORWH; NIA; NIAMS; NIDA; NIMHD; NLM; NIDCR; OBSSR; OAR; SGMRO |
| ORWH’s U3 program (Understudied, Underrepresented, and Underreported) includes administrative supplements (NOT-OD-22-208) targeting interdisciplinary, transdisciplinary, and multidisciplinary research focused on the effects of sex and/or gender influences at the intersection of several social determinants—including, but not limited to, race, ethnicity, socioeconomic status, education, health literacy, gender identity, and urban or rural residence—in human health and illness | ORWH; NEI; NHLBI; NIA; NIAAA; NIAID; NIAMS; NIBIB; NICHD; NIDCD; NIDCR; NIDDK; NIDA; NIEHS; NIGMS; NIMH; NINDS; NINR; NCCIH; NCI; SGMRO; ONR |
| NIAID’s Transgender People: Immunity, Prevention, and Treatment of HIV and STIs R21 (PAR-22-186) will support short duration, high-risk and innovative, hypothesis-generating research focused on describing the systemic and mucosal impact of the drugs, hormones and surgical interventions used for gender reassignment and their impact on susceptibility to HIV and other sexually transmitted infections (STI) in transgender people | NIAID |
| NIAID’s American Women: Assessing Risk Epidemiologically (AWARE) R01 (RFA-AI-21-058) will support research that combines epidemiologic methods, digital technology, and data science approaches to better understand HIV prevention, transmission, and early care-cascade points for women living in the USA | NIAID; NIAAA; NICHD; NIDA; NIMH; OBSSR; ORWH |
| NICHD’s Multipurpose Prevention Technology: Novel Systemic Options for Young Adults R43/R44 (PAR-21-297) and NIAID’s Next Generation Multipurpose Prevention Technologies (NGM) R01 (PAR-22-222) will support development of multipurpose technologies that prevent HIV infection and pregnancy (hormonal and non-hormonal methods) in adolescent and young women, and encourages bio-behavioural and behavioural/social studies to identify MPT end user preferences factors (look, feel, effectiveness, safety and duration of action) and other behavioral/social factors that could promote increased MPT use in adolescent and young women | NICHD; NIAID; NIMH |
| NIA’s Sex and Gender Differences in AD/ADRD (NOT-AG-21-050) Notice of Special Interest (NOSI) promotes multidisciplinary research to clarify sex and gender differences in the risk, development, progression, diagnosis, and clinical presentation of Alzheimer’s disease (AD) and Alzheimer’s disease-related dementias (ADRD). It includes social level factors (e.g., history of maltreatment or adversity, parenthood, marital status, educational attainment, socioeconomic and employment status) and healthcare system-level (e.g., access to care) factors and processes that separately, or together, may drive observed differences by sex and gender and/or may operate differently by sex and gender | NIA |
| NIMH’s Notice of Information on High Priority Research Areas for Sex and Gender Influences on the Adolescent Brain and Mental Health of Girls and Young Women (Ages 12-24) (NOT-MH-22-245) outlines NIMH priorities in the field of women’s mental health research, including research projects that examine biological, social, cultural, and behavioural contributions of sex and gender influences on mental illnesses (e.g., anxiety, depression, psychosis, schizophrenia, bipolar disorder, trauma-related disorders, eating disorders, etc.) autism spectrum disorder and suicide in adolescent girls and young women | NIMH |
| NIDA’s Notice of Special Interest (NOSI) on Mechanistic studies on the impact of substance use in sex and gender differences in HIV-associated neurocognitive disorders (NOT-DA-22-047) communicates NIDA’s special interest in understanding the neurobiological bases for sex or gender-specific differences in HIV-associated neurocognitive disorders | NIDA |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
